Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1–a statement of the ESCWorking Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.